• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支持性护理评估、优先排序和推荐系统(SPARK)的初步开发,这是一种症状筛查和管理应用程序。

Initial development of Supportive care Assessment, Prioritization and Recommendations for Kids (SPARK), a symptom screening and management application.

机构信息

Program in Child Health Evaluative Sciences, The Hospital for Sick Children, Peter Gilgan Centre for Research and Learning, 686 Bay Street, Toronto, Ontario, M5G 0A4, Canada.

Rotman School of Management, University of Toronto, 105 St. George Street, Toronto, Ontario, M5S 3E6, Canada.

出版信息

BMC Med Inform Decis Mak. 2019 Jan 10;19(1):9. doi: 10.1186/s12911-018-0715-6.

DOI:10.1186/s12911-018-0715-6
PMID:30630480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6327501/
Abstract

BACKGROUND

We developed Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a web-based application designed to facilitate symptom screening by children receiving cancer treatments and access to supportive care clinical practice guidelines primarily by healthcare providers. The objective was to describe the initial development and evaluation of SPARK from the perspective of children.

IMPLEMENTATION

Development and evaluation occurred in three phases: (1) low fidelity focused on functionality, (2) design focused on "look and feel" and (3) high fidelity confirmed functionality and design. Cognitive interviews were conducted with children receiving cancer treatments 8-18 years of age. Evaluation occurred after every five interviews and changes were guided by a Review Panel. Quantitative evaluation included SPARK ease of use and understandability of SPARK reports.

RESULTS

The number of children included by phase were: low fidelity (n = 30), design (n = 30) and high fidelity (n = 30). Across phases, the median age was 13.2 (range 8.5 to 18.4) years. During low-fidelity and design phases, iterative refinements to SPARK improved website navigation, usability and likability from the perspective of children and established symptom report design. Among the last 10 children enrolled to high-fidelity testing, all (100%) understood how to complete symptom screening, access reports and interpret reports. Among these 10 respondents, all (100%) found SPARK easy to use and 9 (90%) found SPARK reports were easy to understand.

CONCLUSIONS

SPARK is a web-based application which is usable and understandable, and it is now appropriate to use for research. Future efforts will focus on clinical implementation of SPARK.

摘要

背景

我们开发了支持性护理优先排序、评估和推荐系统(SPARK),这是一个基于网络的应用程序,旨在方便接受癌症治疗的儿童进行症状筛查,并主要通过医疗保健提供者获得支持性护理临床实践指南。目的是从儿童的角度描述 SPARK 的初步开发和评估。

实施情况

开发和评估分为三个阶段:(1)低保真度关注功能,(2)设计关注“外观和感觉”,(3)高保真度确认功能和设计。对 8-18 岁接受癌症治疗的儿童进行了认知访谈。每次访谈后进行评估,并由评审小组指导进行更改。定量评估包括 SPARK 的易用性和对 SPARK 报告的理解程度。

结果

每个阶段纳入的儿童人数分别为:低保真度(n=30)、设计(n=30)和高保真度(n=30)。各阶段的中位数年龄为 13.2 岁(范围为 8.5 至 18.4 岁)。在低保真度和设计阶段,对 SPARK 的迭代改进改善了儿童视角下的网站导航、可用性和喜爱程度,并确定了症状报告设计。在高保真度测试的最后 10 名儿童中,所有人(100%)都理解如何完成症状筛查、访问报告和解释报告。在这 10 名受访者中,所有人(100%)都认为 SPARK 易于使用,9 人(90%)认为 SPARK 报告易于理解。

结论

SPARK 是一个基于网络的应用程序,具有易用性和可理解性,现在可以用于研究。未来的工作重点将放在 SPARK 的临床实施上。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/2c7dea7b4396/12911_2018_715_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/38bd0a63be53/12911_2018_715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/88792879493a/12911_2018_715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/685b4ce8b8c7/12911_2018_715_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/1285b44d16b5/12911_2018_715_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/80d5530dfa9b/12911_2018_715_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/2c7dea7b4396/12911_2018_715_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/38bd0a63be53/12911_2018_715_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/88792879493a/12911_2018_715_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/685b4ce8b8c7/12911_2018_715_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/1285b44d16b5/12911_2018_715_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/80d5530dfa9b/12911_2018_715_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ce2/6327501/2c7dea7b4396/12911_2018_715_Fig6_HTML.jpg

相似文献

1
Initial development of Supportive care Assessment, Prioritization and Recommendations for Kids (SPARK), a symptom screening and management application.支持性护理评估、优先排序和推荐系统(SPARK)的初步开发,这是一种症状筛查和管理应用程序。
BMC Med Inform Decis Mak. 2019 Jan 10;19(1):9. doi: 10.1186/s12911-018-0715-6.
2
Longitudinal evaluation of Supportive care Prioritization, Assessment and Recommendations for Kids (SPARK), a symptom screening and management application.支持性护理优先化、评估和建议工具(SPARK)的纵向评估,这是一种症状筛查和管理应用。
BMC Cancer. 2019 May 16;19(1):458. doi: 10.1186/s12885-019-5662-9.
3
Development of the SPARK family member web pages to improve symptom management for pediatric patients receiving cancer treatments.开发 SPARK 家族成员网页,以改善接受癌症治疗的儿科患者的症状管理。
BMC Cancer. 2020 Sep 25;20(1):923. doi: 10.1186/s12885-020-07433-9.
4
Feasibility of a randomized controlled trial of symptom screening and feedback to healthcare providers compared with standard of care using the SPARK platform.使用 SPARK 平台对症状筛查和反馈给医疗保健提供者与标准护理进行随机对照试验的可行性。
Support Care Cancer. 2020 Jun;28(6):2729-2734. doi: 10.1007/s00520-019-05115-2. Epub 2019 Nov 9.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Details of development of the resource for adults with asthma in the RAISIN (randomized trial of an asthma internet self-management intervention) study.RAISIN(哮喘互联网自我管理干预随机试验)研究中成人哮喘资源的开发详情。
BMC Med Inform Decis Mak. 2015 Jul 28;15:57. doi: 10.1186/s12911-015-0177-z.
8
Development of mini-SSPedi for children 4-7 years of age receiving cancer treatments.为接受癌症治疗的 4-7 岁儿童开发 mini-SSPedi。
BMC Cancer. 2019 Jan 8;19(1):32. doi: 10.1186/s12885-018-5210-z.
9
Designing and evaluating a web-based self-management site for patients with type 2 diabetes--systematic website development and study protocol.设计和评估一个针对 2 型糖尿病患者的基于网络的自我管理网站——系统的网站开发和研究方案。
BMC Med Inform Decis Mak. 2012 Jun 24;12:57. doi: 10.1186/1472-6947-12-57.
10
Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.面向医疗保险人群的远程医疗:儿科、产科及临床医生间接居家干预措施
Evid Rep Technol Assess (Summ). 2001 Aug(24 Suppl):1-32.

引用本文的文献

1
Factors Associated With Symptom Burden Among Pediatric Patients With Cancer.癌症患儿症状负担的相关因素
JCO Oncol Pract. 2025 Aug 14:OP2500244. doi: 10.1200/OP-25-00244.
2
Factors Associated With Self-Report Symptom Screening Adherence in Pediatric Cancer Patients.与儿科癌症患者自我报告症状筛查依从性相关的因素。
Cancer Med. 2025 Jul;14(14):e71053. doi: 10.1002/cam4.71053.
3
Symptom Screening for Hospitalized Pediatric Patients With Cancer: A Randomized Clinical Trial.住院癌症患儿的症状筛查:一项随机临床试验

本文引用的文献

1
Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.验证《儿科症状筛查代理版工具》在接受癌症治疗的儿童中的适用性。
J Pain Symptom Manage. 2018 Jul;56(1):107-112. doi: 10.1016/j.jpainsymman.2018.03.025. Epub 2018 Apr 6.
2
Describing symptoms using the Symptom Screening in Pediatrics Tool in hospitalized children with cancer and hematopoietic stem cell transplant recipients.用儿科症状筛查工具描述癌症住院患儿和造血干细胞移植受者的症状。
Cancer Med. 2018 May;7(5):1750-1755. doi: 10.1002/cam4.1433. Epub 2018 Mar 23.
3
Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments.
JAMA Pediatr. 2025 Jan 1;179(1):11-18. doi: 10.1001/jamapediatrics.2024.4727.
4
Symptom Screening Linked to Care Pathways for Pediatric Patients With Cancer: A Randomized Clinical Trial.癌症患儿症状筛查与护理路径的关联:一项随机临床试验
JAMA. 2024 Dec 17;332(23):1981-1991. doi: 10.1001/jama.2024.19585.
5
Children and young people's preferences and needs when using health technology to self-manage a long-term condition: a scoping review.儿童和青少年在使用健康技术自我管理长期疾病时的偏好和需求:范围综述。
Arch Dis Child. 2024 Sep 25;109(10):826-835. doi: 10.1136/archdischild-2023-326044.
6
Healthcare professional perspectives following implementation of an infection management care pathway for pediatric patients with cancer: a qualitative study.医疗机构专业人员对感染管理护理路径在癌症患儿中的应用的看法:一项定性研究。
Support Care Cancer. 2024 Jun 4;32(7):405. doi: 10.1007/s00520-024-08612-1.
7
Chemo assist for children mobile health application to manage chemotherapy-related symptoms in acute leukemia in Indonesia: a user-centered design approach.化疗辅助儿童移动健康应用程序在印度尼西亚管理急性白血病化疗相关症状:以用户为中心的设计方法。
BMC Pediatr. 2023 May 30;23(1):274. doi: 10.1186/s12887-023-04076-0.
8
Patient-Reported Outcomes in Pediatric Patients With Cancer.患儿癌症患者的报告结果。
Am Soc Clin Oncol Educ Book. 2023 May;43:e390272. doi: 10.1200/EDBK_390272.
9
Symptom management care pathway adaptation process and specific adaptation decisions.症状管理护理路径的调整过程和具体的调整决策。
BMC Cancer. 2023 Apr 17;23(1):350. doi: 10.1186/s12885-023-10835-0.
10
Feasibility of three times weekly symptom screening in pediatric cancer patients.每周三次症状筛查在儿科癌症患者中的可行性。
BMC Cancer. 2023 Jan 3;23(1):4. doi: 10.1186/s12885-022-10400-1.
验证《儿科症状筛查工具》在接受癌症治疗的儿童中的应用。
J Natl Cancer Inst. 2018 Jun 1;110(6):661-668. doi: 10.1093/jnci/djx250.
4
Evaluation of the electronic self-report Symptom Screening in Pediatrics Tool (SSPedi).儿科电子自我报告症状筛查工具(SSPedi)的评估
BMJ Support Palliat Care. 2018 Mar;8(1):110-116. doi: 10.1136/bmjspcare-2015-001084. Epub 2016 Nov 1.
5
Priorities for quality care in pediatric oncology supportive care.儿科肿瘤支持性护理中的优质护理重点。
J Oncol Pract. 2015 May;11(3):187-9. doi: 10.1200/JOP.2014.002840. Epub 2015 Mar 10.
6
Refinement of the symptom screening in pediatrics tool (SSPedi).儿科症状筛查工具(SSPedi)的优化
Br J Cancer. 2014 Sep 23;111(7):1262-8. doi: 10.1038/bjc.2014.445. Epub 2014 Aug 7.
7
Initial development of the Symptom Screening in Pediatrics Tool (SSPedi).儿科症状筛查工具(SSPedi)的初步开发。
Support Care Cancer. 2014 Jan;22(1):71-5. doi: 10.1007/s00520-013-1945-x. Epub 2013 Aug 31.
8
Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes.癌症患者发热性中性粒细胞减少症的指南治疗偏差及其对结局的影响。
JAMA Intern Med. 2013 Apr 8;173(7):559-68. doi: 10.1001/jamainternmed.2013.2921.
9
A systematic review of symptom assessment scales in children with cancer.癌症患儿症状评估量表的系统评价。
BMC Cancer. 2012 Sep 26;12:430. doi: 10.1186/1471-2407-12-430.
10
The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER).指南一致的止吐治疗对化疗引起的恶心和呕吐(CINV)的影响:泛欧呕吐登记处(PEER)。
Ann Oncol. 2012 Aug;23(8):1986-1992. doi: 10.1093/annonc/mds021. Epub 2012 Mar 6.